Filip Świątkowski

Dr. Filip Świątkowski

orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 October 2022 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
FŚFilip Świątkowski
Filip Świątkowski
TGTomasz Górnicki
Tomasz Górnicki
KBKacper Bułdyś
Kacper Bułdyś
Mariusz ChabowskiMariusz Chabowski
Mariusz Chabowski
Introduction. Quality of life is a topic increasingly being addressed by researchers. Due to the increasing incidence of colorectal cancer, this issue is particularly relevant. Despite the increasing number of publications on this topic each year, it still requires further research. The aim of this study was to analyze the available literature from the past 10 years, addressing the topic of QoL in patients with colorectal cancer which has been treated surgically. Material and methods. This review is based on 93 articles published between 2012 and 2022. It analyzes the impact of socioeconomic factors, the location and stage of the tumor, stoma and the method of surgical treatment on patients’ QoL and sexual functioning. Results. CRC has a negative impact on patients’ financial status, social functioning, pain and physical functioning. Patients with stage II or III cancer have an overall lower QoL than patients with stage I. The more proximally the lesion is located to the sphincters, the greater the negative impact on the QoL. There was a significant difference in favor of laparoscopic surgery compared with open surgery. In patients with a stoma, the QoL is lower compared with patients with preserved gastrointestinal tract continuity. The more time has passed since surgery, the more the presence of a stoma has a negative impact on QoL. Surgery for CRC negatively affects patients’ sex lives, especially in younger people and among men. Conclusions. This study may contribute to the identification of the factors that affect the QoL of patients with surgically treated colorectal cancer. This will allow even more effective and complete treatment, facilitating patients’ return to normal physical, mental and social functioning.

1 August 2021 in Annals of Vascular Surgery
Verified
Journal Article
Closed access
ATAgnieszka Turowicz
Agnieszka Turowicz
JKJakub Kobecki
Jakub Kobecki
ALAleksandra Laskowska
Aleksandra Laskowska
JWJan Wojciechowski
Jan Wojciechowski
FŚFilip Świątkowski
Filip Świątkowski
Mariusz ChabowskiMariusz Chabowski
Mariusz Chabowski

1 September 2024 in Cancer Management and Research
Verified
Journal Article
Open access
PDF file
FŚFilip Świątkowski
Filip Świątkowski
JLJakub Lambrinow
Jakub Lambrinow
TGTomasz Górnicki
Tomasz Górnicki
MJMarta Jurga
Marta Jurga
Mariusz ChabowskiMariusz Chabowski
Mariusz Chabowski
Introduction: Due to the increasing number of cases and the levels of mortality, colorectal cancer is still a major health problem. Therefore, the growing interest in the quality of life of patients and the assessment of the quality of life of patients with colorectal cancer seems to be particularly important. The aim of the study was to investigate and determine factors that have a significant impact on the QoL of patients who were diagnosed with colorectal cancer that was surgically treated in the Surgical Department of the 4th Military Clinical Hospital in Wroclaw. Methods: 102 respondents were enrolled into the study. The QLQ-C30, QLQ-CR29 as well as an original questionnaire regarding the socioeconomic factors were used for the assessment. The information was supplemented with patients’ clinical data. Results: According to the QLQ-C30 questionnaire the average QoL of the respondents was 55%. Factors such as male gender, younger age, higher BMI, no significant weight loss, living with family, lower level of education and being professionally active have significant positive impact on QoL. In contrary, patients with more advanced and malignant cancer with tumor located in the right half of the colon had worse QoL. The particular domains of QoL influenced by these factors were also identified. Determining these factors will allow for more effective treatment, for the shortening of the hospitalization and finally for the reduction of the costs. Conclusion: The better QoL of the patients with colorectal cancer treated surgically showed younger men, living with family and with the support from close people, professionally active, with primary level of education, and without significant weight loss, ie less than 5% of body weight in the last 6 months. Moreover, patients with cancer located in the left colon, at a lower stage, with a lower grading demonstrated a better QoL.

26 August 2022 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
KSKathie Sarzyńska
Kathie Sarzyńska
FŚFilip Świątkowski
Filip Świątkowski
JJJarosław Janc
Jarosław Janc
JZJan Zabierowski
Jan Zabierowski
BJBeata Jankowska-Polanska
Beata Jankowska-Polanska
Mariusz ChabowskiMariusz Chabowski
Mariusz Chabowski
COVID-19 is a contagious disease that has spread globally, killing millions of people around the world. In order to reduce the likelihood of in-hospital death due to COVID-19, it is reasonable to select a group of patients with a low probability of survival and to implement measures in advance to minimize the risk of death. One way to do this is to establish cut-off values for the most commonly performed blood laboratory tests, above or below which the likelihood of death increases significantly. The aim of the study was to determine the basic laboratory parameters among unvaccinated patients hospitalized for COVID-19 with concomitant cardiovascular disease, which are the predictors of in-hospital death. Out of 1234 patients, 446 people who met the specific inclusion criteria were enrolled in the study. The multivariate regression analysis has shown that the independent predictors of death are: troponin levels of at least 0.033 μg/L (OR = 2.04 [1.10; 3.79]), creatinine of at least 1.88 mg/dL (OR = 2.88 [1.57; 5.30]), D-dimers of at least 0.97 g/L (OR = 2.04 [1.02; 4.07]), and C-reactive protein minimum of 0.89 mg/L (OR = 2.28 [1.24; 4.18]).